Protocatechuic acid treatment also inhibited the expression of MMP-3 and MMP-13 in RA-FLSs, as well as the secretion of inflammatory cytokines TNF-α, IL-1β, and IL-6. This evidence concerns the gene MMP3 and rheumatoid arthritis.